Use of glucagon-like peptide-1 agonists among individuals undergoing bariatric surgery in the US
About The Study: In this retrospective cohort study using a nationwide database, among a cohort of U.S. adults undergoing bariatric surgery, approximately 1 in 10 initiated a glucagon-like peptide-1 receptor agonist. Initiation was greater among women, those undergoing sleeve gastrectomy, and individuals with larger body mass index regain than among their counterparts.
Corresponding Author: To contact the corresponding author, Hemalkumar B. Mehta, MS, PhD, email hbmehta@jhu.edu.
To ...